Zurich Cantonal Bank
BIO icon

Zurich Cantonal Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Zurich Cantonal Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,381
Closed -$1.63M – 2689
2025
Q4 		$1.63M Buy
+5,381
New +$1.68M ﹤0.01% 1065

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Zurich Cantonal Bank's BIO Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Bio-Rad Laboratories Class A (BIO) stake by 5% in Q2 2026, buying an estimated $89.6K and bringing the position to 6,686 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

Zurich Cantonal Bank first reported a position in BIO in Q1 2015 and has held it in 45 quarters since. The position peaked at $6.15M in Q1 2023. 401 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Zurich Cantonal Bank held 6,686 shares of Bio-Rad Laboratories Class A worth $1.96M as of Q2 2026.
  • Zurich Cantonal Bank bought 316 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $89.6K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1152 holding.
  • Zurich Cantonal Bank first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and has held it in 45 quarters since.
  • Zurich Cantonal Bank's Bio-Rad Laboratories Class A position peaked at $6.15M in Q1 2023.
  • 401 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.